Delaware Regulators Reject ChristianaCare’s Planned Downstate Campuses
Delaware regulators voted 8-1 to reject ChristianaCare’s proposed $123 million microhospital campuses in Camden and Georgetown, siding with competing downstate health systems that warned of service duplication and rising costs.

In this piece
The Delaware Health Resources Board denied ChristianaCare's applications to build two neighborhood hospital campuses in Kent and Sussex counties following an…
Delaware healthcare regulators have formally rejected ChristianaCare’s ambitious bid to construct two new neighborhood hospital campuses in central and southern Delaware. In an 8-1 decision, the Delaware Health Resources Board denied the health system's certificate of public review applications for planned microhospitals in Kent and Sussex counties, halting a proposed expansion valued at more than $123 million.
Under the rejected proposal, ChristianaCare planned to build a $58.1 million facility in Camden, located in Kent County, alongside a $65.1 million campus in Georgetown in Sussex County. The proposed neighborhood hospital model called for small-scale inpatient facilities featuring emergency departments, imaging services, and around-the-clock observation beds. To develop and operate the sites, ChristianaCare had partnered with Texas-based Emerus Holdings, a major nationwide operator of microhospitals.
The expansion plan encountered fierce and unified resistance from incumbent hospital systems operating across southern Delaware, including Bayhealth, Beebe Healthcare, and TidalHealth. Hospital executives from those competing institutions testified that the new facilities would unnecessarily duplicate existing emergency and acute care services already available to residents. Opponents warned that fragmenting patient volumes would destabilize regional healthcare delivery without lowering treatment expenses.
Opponents also raised pointed financial concerns, arguing that the introduction of microhospitals would drive up overall healthcare costs for regional employers and patients. Healthcare leaders in downstate Delaware cautioned that freestanding emergency departments and microhospitals often capture high-reimbursement emergency visits while diverting critical clinical staff away from full-service community hospitals. In a market already facing persistent nursing and physician shortages, rivals argued the new centers would intensify competition for qualified personnel.
During the review process, members of the Delaware Health Resources Board closely scrutinized ChristianaCare's application data and projections. Regulators identified notable discrepancies in the health system's utilization forecasts and questioned whether ChristianaCare had demonstrated a verifiable community need under state review standards. Board members also raised procedural questions regarding patient transfer protocols for individuals requiring higher levels of acute care than microhospitals can provide.
Scrutiny further centered on ChristianaCare's joint venture with Emerus Holdings and how the partnership conformed to Delaware’s healthcare regulations. Competing health networks argued that introducing a for-profit management partner conflicted with established nonprofit regulatory benchmarks in the state. State board members weighed whether the joint venture structure sufficiently protected public interest and transparent community oversight.
ChristianaCare leadership expressed profound disappointment with the board’s decision, defending the downstate investment as a vital response to regional demographic shifts. Health system officials emphasized that Kent and Sussex counties represent some of Delaware’s fastest-growing and oldest populations, creating an escalating demand for accessible outpatient and emergency care. The organization maintained that neighborhood campuses would offer high-quality, convenient access points closer to where southern Delaware residents live.
The regulatory rejection highlights the broader commercial and logistical tensions surrounding healthcare expansion across Delaware's central and southern communities. As retirees and new residents continue to relocate downstate, healthcare providers have increasingly competed to secure market share and establish outpatient facilities along major travel corridors. State regulators remain tasked with balancing the pressure for localized access against the statutory obligation to prevent costly service duplication.
Following the decisive denial, ChristianaCare announced that it will review the board's findings and evaluate its strategic options moving forward. The healthcare system retains the ability to appeal the administrative decision through state courts or submit modified proposals addressing the board’s specific evidentiary concerns. For now, incumbent downstate providers view the ruling as a significant validation of their efforts to preserve integrated regional care models.
Primary source: Google News Delaware. Newzly rewrites and structures source reporting for clarity; verify critical details at the original.